Free Trial

Rhumbline Advisers Raises Stock Holdings in Astera Labs, Inc. $ALAB

Astera Labs logo with Computer and Technology background

Key Points

  • Rhumbline Advisers increased its stake in Astera Labs by 4.4%, owning approximately 104,345 shares valued at $6.23 million as of the latest SEC filing.
  • A total of 60.47% of Astera Labs' stock is held by institutional investors, signaling strong institutional interest in the company.
  • Astera Labs reported a 149.5% year-over-year revenue increase, achieving $191.93 million for the quarter, while EPS surpassed estimates at $0.44.
  • Five stocks we like better than Astera Labs.

Rhumbline Advisers boosted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 4.4% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 104,345 shares of the company's stock after acquiring an additional 4,396 shares during the quarter. Rhumbline Advisers owned 0.06% of Astera Labs worth $6,226,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Geneos Wealth Management Inc. increased its position in Astera Labs by 1,382.7% during the first quarter. Geneos Wealth Management Inc. now owns 4,033 shares of the company's stock valued at $241,000 after acquiring an additional 3,761 shares during the last quarter. Focus Partners Wealth increased its position in Astera Labs by 0.8% in the first quarter. Focus Partners Wealth now owns 432,806 shares of the company's stock worth $25,826,000 after buying an additional 3,464 shares in the last quarter. Optimize Financial Inc purchased a new stake in Astera Labs in the first quarter worth about $1,718,000. Empowered Funds LLC increased its position in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company's stock worth $277,000 after buying an additional 4,183 shares in the last quarter. Finally, Fred Alger Management LLC increased its position in Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after buying an additional 179,638 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Analysts Set New Price Targets

A number of analysts have commented on the company. Evercore ISI upped their price target on Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 6th. Northland Capmk cut Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. Deutsche Bank Aktiengesellschaft upped their price target on Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a research report on Tuesday, September 2nd. Barclays restated an "overweight" rating and issued a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. Finally, Northland Securities cut Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price target for the company. in a research report on Tuesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $142.00.

Check Out Our Latest Research Report on Astera Labs

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 91,441 shares of the firm's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the sale, the chief operating officer directly owned 2,170,877 shares of the company's stock, valued at $398,377,638.27. This trade represents a 4.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Manuel Alba sold 183,000 shares of the firm's stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the sale, the director directly owned 385,863 shares of the company's stock, valued at $66,858,482.01. The trade was a 32.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,832,489 shares of company stock worth $264,172,396. 12.50% of the stock is currently owned by company insiders.

Astera Labs Stock Up 0.8%

Astera Labs stock traded up $1.79 during midday trading on Monday, reaching $231.29. 3,248,667 shares of the stock traded hands, compared to its average volume of 4,959,556. The stock's fifty day moving average is $155.12 and its 200-day moving average is $104.02. Astera Labs, Inc. has a 12 month low of $42.80 and a 12 month high of $237.82. The stock has a market cap of $38.44 billion, a P/E ratio of 413.02, a PEG ratio of 5.82 and a beta of 1.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The company had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same period in the prior year, the company earned $0.13 earnings per share. The firm's revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

See Also

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.